Orange Book product · Brand (NDA)

EMEND

APREPITANT

Brand (NDA)NDA 021549TE ABRX MSD

Mar 26, 2003

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Mar 26, 2003
23 yr 7 mo ago
Today
Patent 8258132 expires
Listed drug product patent expiration.
Sep 26, 2027
in 1 yr 3 mo
Patent 8258132 expires
Listed drug product patent expiration.
Sep 26, 2027
in 1 yr 3 mo

Active ingredient

APREPITANT

Strength

125MG

Dosage form

CAPSULE

Route

ORAL

TE code

Application

NDA 021549

Product number

002

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8258132	Sep 26, 2027	in 1 yr 3 mo	ProductU-901
8258132	Sep 26, 2027	in 1 yr 3 mo	ProductU-1743